Developing Drug Strategies for the Neuroprotective Treatment: 2nd Edition
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 249
Special Issue Editor
2. Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan
Interests: natural products; neuroscience; neuropharmacology; epilepsy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological disorders are a major public health problem that constitutes more than 6% of the global burden of disease. Among diseases of the central and peripheral nervous systems, the most common neurological disorders are epilepsy, Alzheimer's disease, multiple sclerosis, cerebrovascular diseases, Parkinson's disease, and traumatic disorders. The main pathogenesis mechanism of neurological disorders is the abnormality or death of brain cells caused by excitotoxic effects, the disturbance of cellular energy metabolism, and oxidative stress. However, the pharmacological treatment of neurological disorders faces many challenges. Firstly, the available and currently used drugs do not provide a cure. Secondly, they are also associated with toxicity and adverse reactions. Hence, the development of newer and safer neuroprotective drugs has become a major goal. The purpose of this Special Issue of Molecules is to collect original research articles and reviews on the potential strategies for the treatment of neurological disorders.
Prof. Dr. Su-Jane Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurological disease
- neuroprotectant
- drug discovery
- chemical synthesis
- natural products
- drug targeting
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
